← back to search

Don N. Wickramasinghe

King's College London · GB
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Antifungal resistance and susceptibility, Fungal Infections and Studies, Antimicrobial Peptides and Activities, and Peptidase Inhibition and Analysis.
h-index
5
citations
160
works
9
NIH funding
primary concept
email

Recent publications

Candidalysins Are a New Family of Cytolytic Fungal Peptide Toxins
mBio 2022cited by 69position: middledoi
Receptor-kinase EGFR-MAPK adaptor proteins mediate the epithelial response to Candida albicans via the cytolytic peptide toxin, candidalysin
Journal of Biological Chemistry 2022cited by 21position: middledoi
Candidalysin Is a Potent Trigger of Alarmin and Antimicrobial Peptide Release in Epithelial Cells
Cells 2020cited by 53position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Julian R. Naglik · King's College London3 papers (2020–2022)Jemima Ho · King's College London3 papers (2020–2022)Jonathan P. Richardson · King's College London3 papers (2020–2022)Nicole O. Ponde · University of Pittsburgh2 papers (2022–2022)Olivia W. Hepworth · Harvard University2 papers (2022–2022) · 2 papers (2020–2022)David L. Moyes · King's College London2 papers (2022–2022)Antzela Tsavou · King's College London2 papers (2022–2022)Natalia K. Kotowicz · King's College London1 papers (2022–2022)Léa Lortal · University of California, San Francisco1 papers (2022–2022)Corinne Maufrais · Institut Pasteur1 papers (2022–2022) · 1 papers (2022–2022)Spyridoula-Angeliki Nikou · University College London1 papers (2020–2020)Nessim Kichik · King's College London1 papers (2022–2022)Duncan Wilson · University of Tübingen1 papers (2022–2022)Sejeong Lee · Salisbury University1 papers (2022–2022)Ana Gallego-Cortés · Vall d'Hebron Institut de Recerca1 papers (2022–2022)Rhys Brown · King's College London1 papers (2022–2022)Emily Priest · King's College London1 papers (2022–2022)Sarah L. Gaffen · University of Pittsburgh1 papers (2022–2022)